Erkut Borazanci
0000-0001-5136-5462
Publication & Citation Trends
Publications
0 total
Abstract 2226: Novel targeted therapies for malignant ascites in pancreatic cancer.
Cited by 0
Semantic Scholar
Abstract 6497: Synergistic disruption of KRAS and FAK pathways: A preclinical pipeline for PDAC therapy optimization
Cited by 0
Semantic Scholar
Phase II Trial of Vemurafenib and Sorafenib Combination in Advanced KRAS-Mutated Metastatic Pancreatic Cancer
Cited by 0
Semantic Scholar
A phase 2 study to investigate the efficacy and safety of acoustic cluster therapy with modified FOLFIRINOX in patients with locally advanced pancreatic cancer.
Cited by 0
Semantic Scholar
Abstract 2526: Non-invasive biomarker discovery and validation for the early detection of pancreatic cancer
Cited by 0
Semantic Scholar
Performance of a blood-biomarker test for early detection of pancreatic ductal adenocarcinoma (PDAC) across all stages of disease versus a mixed control population.
Cited by 0
Semantic Scholar
Validation of a Serum-Based Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma.
Cited by 8
Semantic Scholar
S5 High Performance of a Blood-Based Biomarker Test to Detect Early-Stage Pancreatic Cancer in a High-Risk Population, Across 2 Independent Clinical Validation Studies
Cited by 0
Semantic Scholar
Research Topics
Pancreatic and Hepatic Oncology Research
(164)
Cancer Genomics and Diagnostics
(64)
Epigenetics and DNA Methylation
(50)
Cancer Immunotherapy and Biomarkers
(41)
Neuroendocrine Tumor Research Advances
(38)
Affiliations
Translational Genomics Research Institute
City Of Hope National Medical Center
Arizona Department of Health Services
Institute of Cancer Research
Sarah Cannon Research Institute